In this enlightening episode, we sit down with Dr. Miller, a leading scientific expert in aging research. Dr. Miller dives into Cook's groundbreaking research on interleukin 11 and its implications for expanding lifespans in mice. The discussion explores how targeted anti-aging interventions, such as drugs and neurostimulators, have the potential to revolutionize preventive medicine by focusing on aging itself rather than individual diseases. Key highlights include the Interventions Testing Program (ITP) and the promising results of drugs like rapamycin and canagliflozin. Dr. Miller takes us through historical breakthroughs, the significance of using genetically diverse mice for reliable results, and the collaborative effort in drug selection within the ITP. The episode also covers exciting concepts like caloric restriction, epigenetic drift, and the potential pitfalls of senolytic drugs. Through the interview, Dr. Miller reflects on the broader impacts of aging research, touching on everything from metabolic processes to inflammation, and the practical challenges of translating these findings to human applications. For those curious about the future of aging research and eager to understand the science behind living healthier, longer lives, this episode is a must-listen. miss out on these invaluable insights—subscribe and stay updated with more fascinating discussions! Contact info: Dr. Navaz Habib Email: [email protected]: https://www.facebook.com/DrNavazHabib/Instagram: https://www.instagram.com/drnavazhabib/LinkedIn: https://ca.linkedin.com/in/drnavazhabib JP ErricoLinkedIn: https://www.linkedin.com/in/jp-errico-097629aa Dr. Richard MillerWebsite: https://www.richmillerlab.com/